1.015USD-11.74%Mkt Cap: 193.63M $P/E: —1d ago
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophage…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap193.63M $
Enterprise Value201.20M $
Revenue (TTM)5.13M $
Gross Profit-1.96M $
Net Income (TTM)-58.01M $
Revenue/Share0.0430 USD
Last Price1.015 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees82
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-5.97
PEG—
EV/EBITDA-4.16
EV/Revenue39.19
P/S37.72
P/B-27.43
EPS (TTM)-0.34
EPS (Forward)-0.17
52W Range
0.900016% of range1.629
52W High1.629 USD
52W Low0.9000 USD
Profitability
Gross Margin-41.73%
Oper. Margin-964.49%
EBITDA Margin0.00%
Profit Margin-1232.68%
ROE-530.45%
ROA-143.43%
Growth
Revenue Growth51.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-46.48M $
CapEx (TTM)197.00K $
FCF Margin-497.13%
FCF Yield-13.18%
Net Debt-2.57M $
Net Debt/EBITDA0.05
Balance Sheet
Debt/Equity2.36
Current Ratio1.07
Quick Ratio1.02
Book Value/Sh-0.0370 USD
Cash/Share0.1540 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)3.950 USD
Upside (mean)+289.2%
Target Range2.000 USD – 9.250 USD
$2.000+289.2% to mean$9.250
# Analysts5
Ownership
Shares Out.190.77M
Float140.58M
Insiders26.53%
Institutions19.41%
Short Interest
Short Ratio5.6d
Short % Float6.11%
Short % Out.4.94%
Shares Short9.42M
Short (prev mo.)6.11M
Technical
SMA 501.026 (-1.1%)
SMA 2001.147 (-11.5%)
Beta1.07
S&P 52W Chg20.25%
Avg Vol (30d)1.52M
Avg Vol (10d)1.56M
Technical Indicators
RSI (14)48.0
MACD0.0015
MACD Signal-0.0003
MACD Hist.+0.0018
BB Upper1.121 USD
BB Middle1.039 USD
BB Lower0.9569 USD
BB Width15.79%
ATR (14)0.0706 USD
Vol Ratio (20d)1.50x